Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Respiratory Tract 03. June 2026
Search
medline.ch
Respiratory Tract
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7960  Previews Next
   
   Articles 1 - 20 / 159194  
   
Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer.
Per Med
Guo H, Li J, Li T, Ruan J.
PMID: 42233655 [PubMed - as supplied by publisher]


Extracellular Vesicles in Exhaled Breath Condensate as Emerging Biomarkers in Lung Cancer.
Am J Physiol Cell Physiol
Schmidt B, Tambon C, Cortopassi F, Bokemeyer C, Saul MJ.
PMID: 42233525 [PubMed - as supplied by publisher]


Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.
Future Oncol
Chen Z, Yang F, Jiang Z, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Moore AC, Lu S.
PMID: 42233228 [PubMed - as supplied by publisher]


Tumor immune microenvironment in non-small cell lung cancer progression.
Front Immunol
Jiang J, Zhong M, Wang J, Zhang Z, Li W, Deng Z.
PMID: 42233035 [PubMed - in process]


Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy.
Front Immunol
May P, Winter C, Hubrecht I, Patenge A, Strathmeyer S, Geyer R, Heelemann S, Stratmann J, Safi S, Klein H, Schneller F, Bassermann F, Becker von Rose A.
PMID: 42233027 [PubMed - in process]


Perioperative outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer: a meta-analysis focusing on real-world clinical studies in the past 10 years.
Front Oncol
Zhu J, Meng X, Hu L.
PMID: 42232542 [PubMed]


Techniques of double-sleeve lobectomy for lung cancer: a narrative review of clinical practice.
J Vis Surg
Nameghi FH, Aresu G, Peryt A, Coonar AS.
PMID: 42232282 [PubMed]


Comment On: "Association Between Admission Prognostic Nutritional Index and Pulmonary Infection Status in Hospitalized Lung Cancer Patients: A Retrospective Cohort Study" [Letter].
J Inflamm Res
Dan Q.
PMID: 42232157 [PubMed]


Uniportal video-assisted thoracoscopic surgery segmentectomy for early-stage non-small cell lung cancer: indications and surgical technique.
J Vis Surg
Suzuki J, Watanabe H, Takamori S, Uchida T, Shiono S.
PMID: 42232042 [PubMed]


Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.
Thorac Cancer
Yamauchi K, Matsumoto K, Shiroyama T, Tamiya A, Tamiya M, Tsukaguchi A, Miyazaki A, Komuta K, Mihashi Y, Machiyama H, Kanaoka K, Kuge T, Kinehara Y, Shoshihara N, Niki T, Kato S, Nishikawa Y, Azuma K, Tanaka S, Osa A, Suzuki H, Nagatomo I, Uchida J, Takeda Y, Kumanogoh A.
PMID: 42231603 [PubMed - in process]


Mechanism study of RUNX1/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer.
Respir Res
He C, Li Y, He H, Zhou F, Fu B, Bu J, Wang M, Kong X, Li P, Ni B, Xu S.
PMID: 42231351 [PubMed - as supplied by publisher]


Prospective germline exome and machine learning-based risk score identify predictive and prognostic biomarkers of immunotherapy outcomes in advanced non-small cell lung cancer.
J Transl Med
González-Hernández A, Ríos A, Onieva JL, Cantero A, Rivero-Aguilar M, Paz-López G, Rueda-Domínguez A, Garrido-Barros M, Martínez-Gálvez B, Zafra J, Figueroa-Ortiz LC, Pérez-Ruiz E, Benítez JC, Barragán I, Oliver J.
PMID: 42231301 [PubMed - as supplied by publisher]


Large scale evaluation of a multiple tumor marker panel for lung cancer diagnosis and histological subtyping.
Discov Oncol
Geng J, Li L, Li J, Cao T, Zhou J, Sheng W, Guo H.
PMID: 42231004 [PubMed - as supplied by publisher]


Solasonine suppresses non-small cell lung cancer progression by inhibiting the STAT3/PD-L1 axis.
Sci Rep
Zheng L, Song Q, Liang J.
PMID: 42230729 [PubMed - as supplied by publisher]


The application of rapid ultrasound-guided paraffin technique in the pathological examination of biopsy specimens from non-small cell lung cancer.
Sci Rep
Zhu LH, Yang JR, Xia WX, Qiu YL, Ye XZ, Qi XF.
PMID: 42230693 [PubMed - as supplied by publisher]


Lipid Metabolic Reprogramming in Lung Cancer: Mechanisms and Therapeutic Targets in the Tumor Microenvironment.
Int J Cancer
Wang S, Yu J.
PMID: 42230155 [PubMed - as supplied by publisher]


Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project.
J Thorac Oncol
Dacic S, Shenker D, Redman M, Brunner L, Saqi A, Cooper WA, Borczuk A, Chung JH, Glass C, Lopez JM, Roden AC, Sholl L, Weissferdt A, Brosnan-Cashman J, Hennek S, Grullon S, Posadas J, Fujimoto J, Connolly C, Wynes MW, Sanchez-Espiridion B, Lee JJ, Berezowska S, Chou TY, Kerr K, Nicholson AG, Schalper KA, Tsao MS, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn PA Jr, Kris MG, Travis W, Yu L, Wistuba I, IASLC Pathology Committee.
PMID: 42229633 [PubMed - as supplied by publisher]


[What matters most? Quality of life preferences in lung cancer care treatment from the perspective of patients and physicians - A Systematic Review].
Gesundheitswesen
Friebel S, Ibler K, Emmert M.
PMID: 42229444 [PubMed - as supplied by publisher]


Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis.
Lung Cancer
Wang J, Takundwa R, Yang H, Chai X, Yu Y, Zhang Y, Dirnberger F, Anderson ES, Pastel M, Pundole X, Gomez-Randulfe I, Blackhall F.
PMID: 42229339 [PubMed - as supplied by publisher]


Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis.
Lung Cancer
Liu WH, Cheng YJ, Kang J, Chen J, An ZJ, Li TH, Tan N, Zhong WZ, Wu YL, Jiang L.
PMID: 42229338 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 159194    Page 1 of 7960  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1